PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 66 filers reported holding PAIN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $24,000 | +41.2% | 26,655 | +193.5% | 0.00% | – |
Q3 2015 | $17,000 | +240.0% | 9,083 | +209.4% | 0.00% | – |
Q2 2015 | $5,000 | -91.5% | 2,936 | -89.9% | 0.00% | – |
Q4 2014 | $59,000 | +118.5% | 29,112 | +518.5% | 0.00% | – |
Q2 2014 | $27,000 | -94.4% | 4,707 | -94.6% | 0.00% | -100.0% |
Q1 2014 | $480,000 | +296.7% | 87,260 | +249.4% | 0.00% | – |
Q4 2013 | $121,000 | -49.6% | 24,974 | -71.7% | 0.00% | – |
Q3 2013 | $240,000 | -41.9% | 88,250 | -52.7% | 0.00% | -100.0% |
Q2 2013 | $413,000 | – | 186,732 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |